Skip to content
S5060Senate2023-2024 Session

Review Blood Donations for Illness

Official title

“Relates to review of blood donations of patients with certain illnesses”

Sponsor Michelle HincheySD-41+1 co-sponsorAffects Health
Status
In Assembly Committee
Health
Impact
4/10
Low
Passage
0%

Bill progress

Step 5 of 7

In Assembly · Health

What's happening

This bill requires a review of blood donation policies for people with Lyme or tick-borne illnesses and mandates new recommendations on their eligibility.

Why it matters

  1. Expands research and oversight. By mandating a review of all current medical research on blood donation by people with Lyme or tick-borne illnesses, the bill ensures that policy decisions will be based on up-to-date scientific findings, which could impact both donor eligibility and recipient safety.

  2. Includes a broad range of illnesses. The review isn’t limited to Lyme disease—it covers multiple tick-borne illnesses (such as babesiosis and Powassan virus) and their co-infections, recognizing that blood safety concerns may extend beyond the most well-known diseases.

  3. Requires swift action and transparency. The council must issue recommendations within 90 days, and the health commissioner must immediately share these with legislative leaders, increasing responsiveness and legislative oversight on this public health issue.

  4. Could lead to stricter donor restrictions or moratoriums. The bill specifically calls for recommendations on whether there should be temporary or permanent bans on blood donations from people with these illnesses, which could significantly affect the blood supply and eligibility criteria for donors.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Blood banks and blood collection centers

    The bill would require recommendations on collecting, testing and distributing blood from donors with current or past Lyme or tick-borne illnesses, including possible temporary or permanent collection moratoriums.

  • People with a history of Lyme or tick-borne illnesses

    Their blood donations would be the focus of a required review of current medical research and guidance.

  • The council and state health commissioner

    The council would have 90 days after the bill takes effect to issue recommendations, which the commissioner would immediately forward to legislative leaders.

  • Assembly and Senate leaders

    The Assembly speaker and temporary Senate president would receive the recommendations on blood donation practices and possible collection moratoriums.

Headline styles

Review Blood Donations for Illness

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Michelle Hinchey

Senator · Senate District 41

Chair, Agriculture

1 Co-sponsor

History

  1. Referred to health
  2. Delivered to assembly
  3. Passed senateVote 61–0
  4. Advanced to third reading
  5. 2nd report cal.
  6. 1st report cal.1347
  7. Referred to health
  8. Referred to health

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

5060

2023-2024 Regular Sessions

IN SENATE

February 22, 2023

Introduced by Sen. HINCHEY -- read twice and ordered printed, and when printed to be committed to the Committee on Health

AN ACT to amend the public health law, in relation to donation of blood by patients with a history of Lyme or tick-borne illnesses

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Section 3121 of the public health law is amended by adding a new subdivision 6 to read as follows:

6. (a) The council shall review all current medical research and guidance regarding the donation of blood by patients with a history of Lyme or tick-borne illnesses, including but not limited to:

(i) human anaplasmosis;

(ii) babesiosis;

(iii) human ehrlichiosis;

(iv) Rocky Mountain spotted fever;

(v) Powassan virus;

(vi) Southern tick-associated rash illness; and

(vii) other related illnesses and co-infections.

(b) (i) The council shall, within ninety days after the effective date of this subdivision, issue recommendations to the commissioner regarding the collection, testing, and distribution of blood donations with Lyme and tick-borne illnesses present or reported in a patient history, including but not limited to:

(1) considerations of the current state of medical research; and

(2) recommendations for temporary or permanent moratoriums on the collection of blood with Lyme and tick-borne related illnesses present.

(ii) Upon immediate receipt of such recommendation, the commissioner shall provide a copy of such to the speaker of the assembly and the temporary president of the senate.

§ 2. This act shall take effect immediately.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD09284-01-3

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the public health law, in relation to donation of blood by patients with a history of Lyme or tick-borne illnesses

Purpose

Relates to review of blood donations of patients with certain illnesses

Summary of provisions

Section 1: Amends section 3121 of the public health law to add a new subdivision 6 to require the council on human blood and transfusion services in the Department of Health to review current medical research and guidance related to the donation of blood by patients with a history of Lyme and tick-borne diseases and issue recommendations to the Commis- sioner related to the collection and distribution of such blood.

Section 2: Establishes the effective date.

Justification

In August 2017, the New York State Senate Task Force on Lyme and Tick- Borne Diseases, in conjunction with the Standing Committee on Health, conducted a public hearing to examine the impacts of Lyme and tick-borne illnesses in the state. While New York's history with these illnesses has been extensive, recent cases have highlighted their tragic conse- quences. At the hearing, public health officials, practitioners, and patients, spoke to the need for continued research, public awareness, and medical guidance in the identification, treatment, and prevention of Lyme and tick-borne illnesses.

Included in these discussions, has been concerns expressed over blood donations and transfusions of blood that has Lyme or tick-borne illnesses present. Recent information has shown that these concerns are not unfounded. In 2012, the New York State Council on Human Blood and Transfusion Services issued a report on considerations related to babe- siosis, human ehrlichiosis, and human anaplasmosis infections and blood transfusions. The report noted that transmission of Babesia from blood or blood components was occurring with "increasing frequency," and at that time, there were four cases of transmission of human anaplasmosis in other areas of the country. The same year, the New England Journal of Medicine noted that babesiosis was the pathogen most often spread by blood transfusions. Nationally, it has been estimated that the number of cases of transfusion-transmitted babesiosis have almost quadrupled from the period of 1995-1999 and 2005-2009.

In light of the high rates of infection in New York of Lyme and other tick-borne illnesses, as well as this state's unique status as the epicenter of this public health crisis, the implications these infections have on donated blood is ever-more significant. The FDA, as well as the American Red Cross, have begun research to examine these concerns, along with medical researchers and academic institutions. This legislation will require the Council to reexamine the issues surrounding blood donations and Lyme and tick-borne related illnesses, and issue recommendations to the Commissioner based on current medical knowledge. As information continues to emerge, it is important that the threats of Lyme and tick-borne diseases be reanalyzed in light of new medical information and research.

Legislative history

2021-22: S.2217 Referred to Health

2019-20: S.1303 Referred to Health/ A.3513 Referred to Health

2017-18: S.7208 Passed Senate/ A.9830 Referred to Health

Fiscal implications

To be determined.

Effective date

This act shall take effect immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.